Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 27% ± 6% | |
fibroblast | 3 studies | 21% ± 1% | |
Mueller cell | 3 studies | 19% ± 3% | |
capillary endothelial cell | 3 studies | 17% ± 0% | |
GABAergic neuron | 3 studies | 21% ± 3% | |
glutamatergic neuron | 3 studies | 28% ± 8% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2546.95 | 2640 / 2642 | 97% | 51.98 | 686 / 705 |
adrenal gland | 100% | 3360.03 | 257 / 258 | 95% | 49.89 | 218 / 230 |
kidney | 100% | 2300.74 | 89 / 89 | 89% | 35.29 | 806 / 901 |
breast | 96% | 1345.10 | 441 / 459 | 91% | 80.72 | 1021 / 1118 |
thymus | 94% | 939.36 | 613 / 653 | 90% | 26.59 | 543 / 605 |
ovary | 90% | 818.86 | 162 / 180 | 91% | 67.44 | 391 / 430 |
uterus | 99% | 926.00 | 168 / 170 | 72% | 33.23 | 329 / 459 |
lung | 95% | 1203.38 | 549 / 578 | 68% | 24.63 | 791 / 1155 |
liver | 75% | 1092.77 | 169 / 226 | 74% | 26.24 | 299 / 406 |
esophagus | 79% | 910.81 | 1139 / 1445 | 66% | 24.62 | 121 / 183 |
pancreas | 64% | 318.23 | 209 / 328 | 79% | 26.97 | 140 / 178 |
prostate | 87% | 675.12 | 214 / 245 | 51% | 12.66 | 257 / 502 |
bladder | 86% | 687.05 | 18 / 21 | 49% | 21.33 | 248 / 504 |
intestine | 90% | 1003.30 | 868 / 966 | 36% | 8.61 | 188 / 527 |
skin | 67% | 522.09 | 1207 / 1809 | 56% | 22.00 | 264 / 472 |
spleen | 100% | 1705.34 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 94% | 1527.87 | 1133 / 1204 | 0% | 0 | 0 / 0 |
stomach | 50% | 480.56 | 178 / 359 | 42% | 10.36 | 120 / 286 |
heart | 90% | 1003.49 | 775 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 87% | 906.40 | 1158 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 25.85 | 38 / 45 |
muscle | 47% | 498.44 | 378 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 46% | 1406.98 | 429 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 6.08 | 8 / 29 |
eye | 0% | 0 | 0 / 0 | 19% | 4.10 | 15 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009615 | Biological process | response to virus |
GO_0051607 | Biological process | defense response to virus |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0071360 | Biological process | cellular response to exogenous dsRNA |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0019060 | Biological process | intracellular transport of viral protein in host cell |
GO_0071357 | Biological process | cellular response to type I interferon |
GO_0051097 | Biological process | negative regulation of helicase activity |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0045070 | Biological process | positive regulation of viral genome replication |
GO_0043657 | Cellular component | host cell |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | IFIT1 |
Protein name | Interferon-induced protein with tetratricopeptide repeats 1 (IFIT-1) (Interferon-induced 56 kDa protein) (IFI-56K) (P56) |
Synonyms | IFI56 G10P1 IFNAI1 ISG56 |
Description | FUNCTION: Interferon-induced antiviral RNA-binding protein that specifically binds single-stranded RNA bearing a 5'-triphosphate group (PPP-RNA), thereby acting as a sensor of viral single-stranded RNAs and inhibiting expression of viral messenger RNAs. Single-stranded PPP-RNAs, which lack 2'-O-methylation of the 5' cap and bear a 5'-triphosphate group instead, are specific from viruses, providing a molecular signature to distinguish between self and non-self mRNAs by the host during viral infection. Directly binds PPP-RNA in a non-sequence-specific manner. Viruses evolved several ways to evade this restriction system such as encoding their own 2'-O-methylase for their mRNAs or by stealing host cap containing the 2'-O-methylation (cap snatching mechanism). Exhibits antiviral activity against several viruses including human papilloma and hepatitis C viruses. . |
Accessions | P09914 ENST00000546318.2 [P09914-2] ENST00000371804.4 [P09914-1] |